SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.918
AS - Asia 17.364
EU - Europa 10.005
SA - Sud America 2.666
Continente sconosciuto - Info sul continente non disponibili 605
AF - Africa 366
OC - Oceania 33
Totale 68.957
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.087
SG - Singapore 6.554
CN - Cina 4.262
BR - Brasile 2.033
IT - Italia 1.944
DE - Germania 1.862
VN - Vietnam 1.811
UA - Ucraina 1.708
HK - Hong Kong 1.478
GB - Regno Unito 1.099
TR - Turchia 970
FI - Finlandia 764
BD - Bangladesh 627
FR - Francia 621
SE - Svezia 523
CA - Canada 449
RU - Federazione Russa 428
JP - Giappone 381
PL - Polonia 371
IN - India 321
MX - Messico 230
AR - Argentina 202
ID - Indonesia 180
ZA - Sudafrica 137
NL - Olanda 135
IQ - Iraq 123
BE - Belgio 107
PK - Pakistan 105
CO - Colombia 101
EC - Ecuador 98
ES - Italia 92
PH - Filippine 76
LT - Lituania 61
SA - Arabia Saudita 61
VE - Venezuela 61
AT - Austria 58
UZ - Uzbekistan 58
MY - Malesia 57
MA - Marocco 52
CL - Cile 51
PY - Paraguay 42
TN - Tunisia 37
AE - Emirati Arabi Uniti 33
JM - Giamaica 33
IE - Irlanda 32
CZ - Repubblica Ceca 31
JO - Giordania 31
KR - Corea 31
IR - Iran 30
PE - Perù 29
EG - Egitto 26
KE - Kenya 25
UY - Uruguay 25
IL - Israele 22
NO - Norvegia 22
AU - Australia 21
AL - Albania 19
AZ - Azerbaigian 19
NP - Nepal 19
CH - Svizzera 18
CR - Costa Rica 18
DZ - Algeria 18
RO - Romania 18
LB - Libano 17
BO - Bolivia 16
ET - Etiopia 16
HN - Honduras 15
GR - Grecia 13
NI - Nicaragua 13
PT - Portogallo 13
GT - Guatemala 12
TH - Thailandia 12
KZ - Kazakistan 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
BG - Bulgaria 10
MD - Moldavia 10
NZ - Nuova Zelanda 10
SN - Senegal 10
BH - Bahrain 9
NG - Nigeria 9
PA - Panama 9
DO - Repubblica Dominicana 8
EU - Europa 8
SV - El Salvador 8
LV - Lettonia 7
PR - Porto Rico 7
KG - Kirghizistan 6
OM - Oman 6
PS - Palestinian Territory 6
CI - Costa d'Avorio 5
GE - Georgia 5
HR - Croazia 5
HU - Ungheria 5
RS - Serbia 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BJ - Benin 4
DK - Danimarca 4
GD - Grenada 4
Totale 68.266
Salva come PNG Salva come JPEG
Città #
Ashburn 4.353
Singapore 4.090
Fairfield 3.529
Woodbridge 3.262
Houston 2.155
San Jose 2.144
Jacksonville 1.847
Ann Arbor 1.682
Chandler 1.529
Hong Kong 1.451
Seattle 1.435
Santa Clara 1.389
Beijing 1.352
Wilmington 1.259
Cambridge 1.191
Council Bluffs 786
Dallas 666
Ho Chi Minh City 648
Los Angeles 634
New York 591
Izmir 546
Munich 546
Nanjing 493
Ferrara 473
Princeton 406
Hanoi 392
Lauterbourg 357
Tokyo 355
Warsaw 319
San Diego 314
Boardman 310
Milan 306
Helsinki 273
São Paulo 217
Falkenstein 195
Shanghai 192
Shenyang 154
Hefei 153
Nanchang 153
Dearborn 146
London 144
Toronto 140
Brooklyn 138
Orem 137
Mexico City 136
Falls Church 126
Turku 123
Atlanta 120
Chicago 119
Montreal 118
Tianjin 117
Buffalo 115
The Dalles 115
San Mateo 114
Denver 113
San Francisco 101
Jakarta 100
Phoenix 99
Brussels 98
Frankfurt am Main 98
Jiaxing 96
Moscow 90
Bologna 87
Da Nang 86
Addison 84
Hebei 84
Changsha 83
Johannesburg 82
Mountain View 82
Redwood City 77
Haiphong 75
Bremen 74
Norwalk 74
Porto Alegre 74
Philadelphia 68
Stockholm 68
Rio de Janeiro 67
Washington 67
Boston 66
Jinan 62
Chennai 56
Guangzhou 54
Zhengzhou 53
Rome 52
Auburn Hills 51
Tashkent 50
Belo Horizonte 49
Columbus 48
Manchester 47
Kunming 45
Poplar 45
Baghdad 43
Amsterdam 39
Biên Hòa 39
Lahore 39
Brasília 38
Dhaka 38
Naples 37
Medellín 36
Curitiba 35
Totale 47.104
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.251
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 412
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 399
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 343
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 341
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 303
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 297
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 293
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 292
A new selective antagonist of the nociceptin receptor 282
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 281
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 280
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 274
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 270
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 267
Designing artificial metalloenzymes exploiting the Spy technology: study of a Cu(II)-Spy construct and perspectives 266
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 261
A new ligand for the urotensin II receptor 260
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 260
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 256
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 252
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 249
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 249
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 247
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 246
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 246
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 246
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 245
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 244
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 242
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 242
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 240
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 240
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 240
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 237
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 236
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 235
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 235
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 235
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 234
Cardiovascular effects of nociceptin in unanesthetized mice 233
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 233
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 233
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 232
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 232
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 230
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 230
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 230
Physicochemical stability of cabazitaxel and docetaxel solutions 229
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 228
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 228
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 225
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 222
Neuropeptide S receptor ligands: a patent review (2005-2016) 222
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 221
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 221
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 221
Pharmacological characterization of tachykinin tetrabranched derivatives 221
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 220
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 220
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 219
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 215
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 213
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 213
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 213
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 213
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 212
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 209
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 209
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 209
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 208
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 208
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 207
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 207
Pharmacological characterization of nociceptin receptor: an in vitro study 207
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 206
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer 204
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 204
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 204
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 204
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 204
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 204
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 203
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 203
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 203
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 202
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 202
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 201
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 200
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 200
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 199
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 199
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 198
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 198
Structure-activity study at positions 3 and 4 of human neuropeptide S. 197
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 197
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 196
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 196
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 195
Totale 24.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 309.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.710
Totale 313.288
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.969 0 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.859 417 165 123 473 635 534 194 379 543 21 225 150
2023/20241.915 224 248 114 49 110 296 73 176 41 39 62 483
2024/20258.352 213 185 726 258 995 735 244 608 1.350 842 1.163 1.033
2025/202624.005 2.381 982 2.120 3.012 3.186 1.538 2.855 1.293 2.178 2.652 1.172 636
2026/20272.905 1.864 1.041 0 0 0 0 0 0 0 0 0 0
Totale 68.957